$77.20
▼ -0.0% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
SuanNutra, a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF
International Flavors & Fragrances to Sell Portfolio of Extracts, Vitamins, Food Enhancements to SuanNutra
IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.
Overview
52-week range
$59
$84
71% of range
Avg surprise (last 3)
+8.8%
Avg reaction (last 2)
+0.5%
100% positive
Latest IV / EM
43%
EM ±9.8% · $78 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $1.25 | $1.08 | +15.7% | +4.2% | +1.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.16 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $1.15 | $1.11 | +3.6% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $1.20 | $1.12 | +7.1% | — | +0.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.23 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.66 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.23 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.10 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.11 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | $1.13 | $1.15 | -1.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $1.72B | — | $1.71B | $1.73B | $1.81B | — | $1.87B | $1.82B |
| Gross profit | $1.02B | — | $983M | $1.03B | $1.03B | — | $1.05B | $1.07B |
| Operating income | $273M | — | $226M | $198M | $-903M | — | $249M | $191M |
| Net income | $169M | — | $40M | $612M | $-1.02B | — | $58M | $170M |
| EPS (diluted) | $0.66 | — | $0.16 | $2.38 | $-3.98 | — | $0.23 | $0.66 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $562M | $590M | $621M | $816M | $613M | $469M | $567M | $671M |
| Inventory | $2.25B | $2.25B | $2.32B | $2.37B | $2.25B | $2.13B | $2.20B | $2.16B |
| Total current assets | $5.44B | $5.59B | $5.88B | $5.93B | $8.63B | $7.97B | $8.42B | $8.15B |
| Total assets | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B | $29.93B | $29.54B |
| Long-term debt | $4.74B | $4.74B | $4.74B | $5.68B | $7.60B | $7.56B | $8.63B | $8.60B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $14.12B | $14.15B | $14.24B | $14.40B | $13.18B | $13.83B | $14.78B | $14.25B |